304 related articles for article (PubMed ID: 16239970)
1. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
Gizard F; Amant C; Barbier O; Bellosta S; Robillard R; Percevault F; Sevestre H; Krimpenfort P; Corsini A; Rochette J; Glineur C; Fruchart JC; Torpier G; Staels B
J Clin Invest; 2005 Nov; 115(11):3228-38. PubMed ID: 16239970
[TBL] [Abstract][Full Text] [Related]
2. [The fibrate-activated PPARalpha/p16INK4A pathway inhibits vascular smooth muscle cell proliferation and vascular occlusion].
Gizard F; Staels B
Med Sci (Paris); 2006 Apr; 22(4):351-3. PubMed ID: 16597398
[No Abstract] [Full Text] [Related]
3. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
[TBL] [Abstract][Full Text] [Related]
4. PPARĪ³ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation.
Reil TD; Kashyap VS; Sarkar R; Freishlag J; Gelabert HA
J Surg Res; 2000 Jul; 92(1):108-13. PubMed ID: 10864490
[TBL] [Abstract][Full Text] [Related]
6. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
Wu YJ; Bond M; Sala-Newby GB; Newby AC
Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
[TBL] [Abstract][Full Text] [Related]
7. The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
Gizard F; Nomiyama T; Zhao Y; Findeisen HM; Heywood EB; Jones KL; Staels B; Bruemmer D
Circ Res; 2008 Nov; 103(10):1155-63. PubMed ID: 18818403
[TBL] [Abstract][Full Text] [Related]
8. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery.
Han Y; Deng J; Guo L; Yan C; Liang M; Kang J; Liu H; Graham AM; Li S
Cardiovasc Res; 2008 Jun; 78(3):597-604. PubMed ID: 18267954
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
Zahradka P; Wright B; Fuerst M; Yurkova N; Molnar K; Taylor CG
J Pharmacol Exp Ther; 2006 May; 317(2):651-9. PubMed ID: 16407462
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cell-specific regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1) transcription by Sp1 is mediated via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter.
Kavurma MM; Khachigian LM
J Cell Biochem; 2004 Nov; 93(5):904-16. PubMed ID: 15389873
[TBL] [Abstract][Full Text] [Related]
11. Aging increases p16 INK4a expression in vascular smooth-muscle cells.
Rodriguez-Menocal L; Pham SM; Mateu D; St-Pierre M; Wei Y; Pestana I; Aitouche A; Vazquez-Padron RI
Biosci Rep; 2009 Sep; 30(1):11-8. PubMed ID: 19196247
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of intimal hyperplasia after stenting by over-expression of p15: a member of the INK4 family of cyclin-dependent kinase inhibitors.
Segev A; Nili N; Qiang B; Osherov AB; Giordano FJ; Jaffe R; Gauldie J; Sparkes JD; Fraser AR; Ladouceur-Wodzak M; Butany J; Strauss BH
J Mol Cell Cardiol; 2011 Mar; 50(3):417-25. PubMed ID: 21081134
[TBL] [Abstract][Full Text] [Related]
13. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARĪ± pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
[TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog signaling induces vascular smooth muscle cell proliferation via induction of the G1 cyclin-retinoblastoma axis.
Li F; Duman-Scheel M; Yang D; Du W; Zhang J; Zhao C; Qin L; Xin S
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1787-94. PubMed ID: 20720195
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats.
Yasumoto H; Kim S; Zhan Y; Miyazaki H; Hoshiga M; Kaneda Y; Morishita R; Iwao H
Gene Ther; 2001 Nov; 8(22):1682-9. PubMed ID: 11892835
[TBL] [Abstract][Full Text] [Related]
17. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
[TBL] [Abstract][Full Text] [Related]
18. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
19. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
20. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
